The role of single-agent gemcitabine in the treatment of non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of single-agent gemcitabine in the treatment of non-small-cell lung cancer

Published:1999 Issue: Volume:10 Page:S53-S56
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kelly K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/suppl_5/S53/6672479/10-suppl_5-S53.pdf

Reference38 articles.

1. Cancer Statistics, 1998;Landis;CA Cancer J Clin,1998

2. Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough?;Grilli;J Clin Oncol,1993

3. Polychemotherapy in advanced non-small-cell lung cancer: A meta-analysis;Souquet;Lancet,1993

4. Chemotherapy versus supportive care in advanced non-small-cell lung cancer: Results of a meta-analysis of the literature;Marino;Chest,1994

5. Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated individual patients data from 52 randomised clinical trials;BMJ,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crude polysaccharide from Danggui Buxue decoction enhanced the anti-tumor effect of gemcitabine by remodeling tumor-associated macrophages;International Journal of Biological Macromolecules;2023-07

2. Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination;Frontiers in Immunology;2022-10-10

3. Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801;The Oncologist;2020-05-18

4. Quel traitement pour un patient de PS-2/3 ayant un cancer bronchique non à petites cellules (CBNPC);Revue des Maladies Respiratoires;2007-10

5. Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study;Cancer Chemotherapy and Pharmacology;2007-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3